Blood Type May Predict Risk of Venous Thromboembolism Among Patients With Cancer
Researchers sought to determine whether ABO blood type may impact the risk of developing VTE in patients with cancer.
Researchers sought to determine whether ABO blood type may impact the risk of developing VTE in patients with cancer.
Serum sodium levels in the lower end of the normal range are associated with inferior outcomes in metastatic renal cell carcinoma, a study suggests.
Measuring lymphocytes during or after radiotherapy could provide useful information about infection risk, according to researchers.
Cancer patients with a SARS-CoV-2 infection before vaccination had a higher risk of death after a breakthrough infection.
The median cancer-specific survival was 56.5 months.
Nearly half of non-clear cell renal cell carcinoma samples were classified as proliferative.
Patients with smaller target lesions at baseline were more likely to be long-term survivors.
Iodine concentration and Hounsfield units were associated with treatment response and survival.
The risk of death from any cause was higher with degarelix.
The seroconversion rate was 92%.